Mankind Pharma Ltd

BOM:543904 (India)  
₹ 2063.45 (-1.74%) May 24
43.26
P/B:
8.82
Market Cap:
₹ 826.69B ($ 9.95B)
Enterprise V:
₹ 794.07B ($ 9.56B)
Volume:
33.16K
Avg Vol (2M):
40.03K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Mankind Pharma Ltd ( BOM:543904 ) from 2023 to May 26 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Mankind Pharma stock (BOM:543904) PE ratio as of May 26 2024 is 43.26. More Details

Mankind Pharma Ltd (BOM:543904) PE Ratio (TTM) Chart

To

Mankind Pharma Ltd (BOM:543904) PE Ratio (TTM) Historical Data

Total 257
  • 1
  • 2
  • 3
Mankind Pharma PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-26 43.3 2024-03-14 49.5
2024-05-24 43.3 2024-03-13 47.8
2024-05-23 44.0 2024-03-12 49.7
2024-05-22 44.2 2024-03-11 50.2
2024-05-21 43.7 2024-03-07 50.0
2024-05-17 43.9 2024-03-06 49.6
2024-05-16 43.9 2024-03-05 50.2
2024-05-15 45.9 2024-03-04 50.1
2024-05-14 47.1 2024-03-01 49.9
2024-05-13 45.7 2024-02-29 49.6
2024-05-10 46.9 2024-02-28 47.6
2024-05-09 45.5 2024-02-27 48.7
2024-05-08 45.7 2024-02-26 47.9
2024-05-07 46.5 2024-02-23 50.0
2024-05-06 47.9 2024-02-22 50.8
2024-05-03 48.5 2024-02-21 50.8
2024-05-02 48.9 2024-02-20 50.9
2024-04-30 49.6 2024-02-19 51.5
2024-04-29 50.0 2024-02-16 51.4
2024-04-26 49.7 2024-02-15 51.3
2024-04-25 50.3 2024-02-14 51.2
2024-04-24 50.3 2024-02-13 50.5
2024-04-23 50.2 2024-02-12 51.3
2024-04-22 49.0 2024-02-09 52.1
2024-04-19 49.0 2024-02-08 52.2
2024-04-18 50.3 2024-02-07 49.4
2024-04-16 47.9 2024-02-06 48.7
2024-04-15 47.5 2024-02-05 47.8
2024-04-12 48.6 2024-02-02 47.3
2024-04-10 49.6 2024-02-01 47.5
2024-04-09 49.5 2024-01-31 46.4
2024-04-08 49.5 2024-01-30 47.8
2024-04-05 49.2 2024-01-29 48.7
2024-04-04 48.9 2024-01-25 47.2
2024-04-03 48.9 2024-01-24 47.9
2024-04-02 50.3 2024-01-23 49.7
2024-04-01 48.5 2024-01-19 50.1
2024-03-28 48.2 2024-01-18 49.7
2024-03-27 54.2 2024-01-17 51.1
2024-03-26 52.2 2024-01-16 51.6
2024-03-22 51.4 2024-01-15 51.6
2024-03-21 49.5 2024-01-12 51.6
2024-03-20 49.5 2024-01-11 51.5
2024-03-19 48.9 2024-01-10 49.9
2024-03-18 49.8 2024-01-09 47.6

Mankind Pharma Ltd (BOM:543904) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Mankind Pharma Ltd is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It operates at the intersection of Indian pharmaceutical formulations and consumer healthcare sectors with the aim of providing quality products at affordable prices and has an established track record of building and scaling brands in-house. The company's brands include Manforce, Prega News and Gas-O-Fast.